Stocks Health care DERM
NASDAQ · Health careJourney Medical Corp (DERM)
Journey Medical Corp brought in $68.2M of revenue over the twelve months to June 30, 2026, up 20.9% from a year earlier. It posted a net loss of $6.1M. At June 30, 2026 it held $25.6M in cash against $25.5M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.
Key facts about Journey Medical Corp
- Net worth
- Journey Medical Corp has a market value (market cap) of $127.6M at the latest share price, and shareholders' equity of $32.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $61.9M (+10.2% year on year), with a net loss of $11.4M. Over the 12 months to June 30, 2026: revenue $68.2M, net loss $6.1M.
- Cash flow
- In fiscal 2025 operations used $12.4M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 12, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Journey Medical Corp's next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Journey Medical Corp does
Journey Medical Corp is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker DERM.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $61.9M | -$11.4M | -$0.47 | n/a |
| 2024 | $56.1M | -$14.7M | -$0.72 | -$24.1M |
| 2023 | $79.2M | -$3.9M | -$0.21 | $240K |
| 2022 | $73.7M | -$29.6M | -$1.69 | -$33.5M |
| 2021 | $63.1M | -$44M | -$4.32 | n/a |
| 2021 | $44.5M | $5.3M | $0.49 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where DERM ranks in Health care
Latest SEC filings
What Journey Medical Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 9, 2026Passive stake changed SCHEDULE 13G/A
- August 12, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 23% to $18.5M versus the same quarter last year; diluted EPS -$0.01 versus -$0.16.
- August 12, 2026
- July 31, 2026Passive stake changed SCHEDULE 13G/A
- July 15, 2026Passive stake changed SCHEDULE 13G/A
- June 26, 2026
- May 13, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 21% to $16M versus the same quarter last year; diluted EPS -$0.08 versus -$0.18.
- May 13, 2026
- April 30, 2026Additional proxy material DEFA14A
- April 30, 2026Proxy statement DEF 14A
Insider trades
What the people running Journey Medical Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| July 1, 2026 | Herskowitz NeilDirector | Received as pay | 50,000 | - |
| July 1, 2026 | Smith Justin AdamDirector | Received as pay | 50,000 | - |
| July 1, 2026 | Toledano Miranda JayneDirector | Received as pay | 50,000 | - |
| June 25, 2026 | Toledano Miranda JayneDirector | Received as pay | 10,000 | - |
| June 25, 2026 | Rosenwald Lindsay A MdDirector | Received as pay | 10,000 | - |
| June 25, 2026 | Pearce Michael CooperDirector | Received as pay | 10,000 | - |
| June 25, 2026 | Herskowitz NeilDirector | Received as pay | 10,000 | - |
| June 25, 2026 | Smith Justin AdamDirector | Received as pay | 10,000 | - |
Who owns DERM
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Wasatch Advisors LP13G, passive | 13.3% | July 15, 2026 |
| Tang Capital Management, LLC13G, passive with 5 related filers | 8% | May 15, 2025 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 71 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Wasatch Advisors LP | 2,858,930 | +725,560 |
| Tang Capital Management LLC | 1,610,000 | 0 |
| Vanguard Capital Management LLC | 675,185 | -406,895 |
| Punch & Associates Investment Management, Inc. | 536,000 | new |
| Pale Fire Capital SE | 528,584 | +46,597 |
| Opaleye Management Inc. | 350,000 | -610,000 |
| Summit Financial, LLC | 346,748 | -33,059 |
| Jane Street Group, LLC | 320,021 | new |
| Diametric Capital, LP | 295,663 | +99,251 |
| Ikarian Capital, LLC | 251,436 | 0 |
| Renaissance Technologies LLC | 229,700 | -12,800 |
| Geode Capital Management, LLC | 216,004 | -247,198 |
| American Financial Group Inc | 180,000 | 0 |
| Trexquant Investment LP | 171,338 | +143,242 |
| Marshall Wace, Llp | 139,843 | new |
| J. Goldman & Co LP | 137,584 | -362,604 |
| Millennium Management LLC | 110,016 | -273,051 |
| BlackRock, Inc. | 100,981 | -871,881 |
| XTX Topco Ltd | 100,923 | +71,559 |
| Vanguard Fiduciary Trust Co | 94,729 | -42,977 |
Insiders
8 insiders reported holding 4,153,077 shares in total, about $18.8M at the last price.
| Holder | Shares |
|---|---|
| Maraoui ClaudePresident & CEO, Director | 2,435,990 |
| Alloush RamseyChief Operating Officer | 598,543 |
| Benesch JosephCFO | 261,371 |
| Smith Justin AdamDirector | 231,618 |
| Rosenwald Lindsay A MdDirector | 221,146 |
| Toledano Miranda JayneDirector | 168,618 |
| Herskowitz NeilDirector | 168,618 |
| Pearce Michael CooperDirector | 67,173 |
Questions about DERM
What does Journey Medical Corp do?
Journey Medical Corp is a company in the Health care sector, listed on NASDAQ as DERM. Its shares trade on NASDAQ under the ticker DERM.
What is Journey Medical Corp's net worth?
Journey Medical Corp has a market value (market cap) of $127.6M at the latest share price, and shareholders' equity of $32.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Journey Medical Corp profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $6.1M on revenue of $68.2M.
How much revenue does Journey Medical Corp make?
Over the twelve months to June 30, 2026 Journey Medical Corp reported revenue of $68.2M. That is 20.9% more than a year earlier.
When did Journey Medical Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake changed from October 9, 2026.
When is Journey Medical Corp's next earnings report?
Journey Medical Corp's next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare DERM with
Follow DERM
Get an email when Journey Medical Corp files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Journey Medical Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.